Table 3.
Adverse Events Upon Osimertinib 160 mg
| Grades 1–2 | Grade 3 | Grades 4–5 | |
|---|---|---|---|
| Diarrhea | 5/11 (45%) | 0 | 0 |
| Fatigue | 3/11 (27%) | 1/11 (9%) | 0 |
| Nail toxicity | 2/11 (18%) | 2/11 (18%) | 0 |
| Rash | 3/11 (27%) | 0 | 0 |
| Dry skin | 4/11 (36%) | 0 | 0 |
| Pruritus | 3/11 (27%) | 0 | 0 |
| Headache | 4/11 (36%) | 0 | 0 |
| Constipation | 1/11 (9%) | 0 | 0 |
| Thrombocytopenia | 2/11 (18%) | 0 | 0 |
| Decrease appetite | 3/11 (27%) | 0 | 0 |
| Leukopenia | 1/11 (9%) | 0 | 0 |
| Acne | 1/11 (9%) | 0 | 0 |